Faeth Therapeutics, Inc. (FTH) income statement
FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.72−0.32 (-3.54%)
Close on Nov 18, 2026Market cap $225.33MP/E –Yield –
Faeth Therapeutics, Inc. financial ratios
See a number that looks wrong?